I know $SHMD just bagged everyone, but 2H26 is likely the real inflection. EBITDA margins guided to ~15%. Order book is seeing a real ramp. The substrate market is incredibly tight. Management obviously has to deliver, but a pretty attractive entry point if guidance is achievable